Literature DB >> 12048243

Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage.

Piyajit Watcharasit1, Gautam N Bijur, Jaroslaw W Zmijewski, Ling Song, Anna Zmijewska, Xinbin Chen, Gail V W Johnson, Richard S Jope.   

Abstract

Glycogen synthase kinase-3beta (GSK3beta) is a central figure in Wnt signaling, in which its activity is controlled by regulatory binding proteins. Here we show that binding proteins outside the Wnt pathway also control the activity of GSK3beta. DNA damage induced by camptothecin, which activates the tumor suppressor p53, was found to activate GSK3beta. This activation occurred by a phosphorylation-independent mechanism involving direct binding of GSK3beta to p53, which was confined to the nucleus where p53 is localized, and mutated p53 (R175H) bound but did not activate GSK3beta. Activation of GSK3 promoted responses to p53 including increases in p21 levels and caspase-3 activity. Thus, after DNA damage there is a direct interaction between p53 and GSK3beta, and these proteins act in concert to regulate cellular responses to DNA damage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12048243      PMCID: PMC123001          DOI: 10.1073/pnas.122062299

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Phosphoinositide 3-OH kinase (PI3K) and PKB/Akt delay the onset of p53-mediated, transcriptionally dependent apoptosis.

Authors:  P Sabbatini; F McCormick
Journal:  J Biol Chem       Date:  1999-08-20       Impact factor: 5.157

2.  Surfing the p53 network.

Authors:  B Vogelstein; D Lane; A J Levine
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

Review 3.  The DNA damage response: putting checkpoints in perspective.

Authors:  B B Zhou; S J Elledge
Journal:  Nature       Date:  2000-11-23       Impact factor: 49.962

Review 4.  Defying death after DNA damage.

Authors:  T Rich; R L Allen; A H Wyllie
Journal:  Nature       Date:  2000-10-12       Impact factor: 49.962

5.  Definition of the p53 functional domains necessary for inducing apoptosis.

Authors:  J Zhu; S Zhang; J Jiang; X Chen
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

Review 6.  GSK-3: new thoughts on an old enzyme.

Authors:  D M Ferkey; D Kimelman
Journal:  Dev Biol       Date:  2000-09-15       Impact factor: 3.582

7.  Specificity and mechanism of action of some commonly used protein kinase inhibitors.

Authors:  S P Davies; H Reddy; M Caivano; P Cohen
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

8.  Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal.

Authors:  M Hetman; J E Cavanaugh; D Kimelman; Z Xia
Journal:  J Neurosci       Date:  2000-04-01       Impact factor: 6.167

9.  The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel.

Authors:  Y Mitsuuchi; S W Johnson; M Selvakumaran; S J Williams; T C Hamilton; J R Testa
Journal:  Cancer Res       Date:  2000-10-01       Impact factor: 12.701

10.  Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification.

Authors:  G H Farr; D M Ferkey; C Yost; S B Pierce; C Weaver; D Kimelman
Journal:  J Cell Biol       Date:  2000-02-21       Impact factor: 10.539

View more
  96 in total

Review 1.  GSK-3: tricks of the trade for a multi-tasking kinase.

Authors:  Bradley W Doble; James R Woodgett
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

2.  AMP-activated protein kinase (AMPK) activating agents cause dephosphorylation of Akt and glycogen synthase kinase-3.

Authors:  Taj D King; Ling Song; Richard S Jope
Journal:  Biochem Pharmacol       Date:  2006-03-10       Impact factor: 5.858

3.  Muscarinic receptor activation protects cells from apoptotic effects of DNA damage, oxidative stress, and mitochondrial inhibition.

Authors:  Patrizia De Sarno; Svetlana A Shestopal; Taj D King; Anna Zmijewska; Ling Song; Richard S Jope
Journal:  J Biol Chem       Date:  2003-01-21       Impact factor: 5.157

4.  A new class of molecular targeted radioprotectors: GSK-3beta inhibitors.

Authors:  Dinesh K Thotala; Ling Geng; Amy K Dickey; Dennis E Hallahan; Eugenia M Yazlovitskaya
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-02-01       Impact factor: 7.038

5.  Mutation in Osteoactivin Promotes Receptor Activator of NFκB Ligand (RANKL)-mediated Osteoclast Differentiation and Survival but Inhibits Osteoclast Function.

Authors:  Samir M Abdelmagid; Gregory R Sondag; Fouad M Moussa; Joyce Y Belcher; Bing Yu; Hilary Stinnett; Kimberly Novak; Thomas Mbimba; Matthew Khol; Kurt D Hankenson; Christopher Malcuit; Fayez F Safadi
Journal:  J Biol Chem       Date:  2015-04-02       Impact factor: 5.157

6.  Endoplasmic reticulum stress accelerates p53 degradation by the cooperative actions of Hdm2 and glycogen synthase kinase 3beta.

Authors:  Olivier Pluquet; Li-Ke Qu; Dionissios Baltzis; Antonis E Koromilas
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

7.  Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance.

Authors:  Roman Kulikov; Karen A Boehme; Christine Blattner
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

Review 8.  The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways.

Authors:  Eléonore Beurel; Richard S Jope
Journal:  Prog Neurobiol       Date:  2006-08-28       Impact factor: 11.685

9.  Unregulated mitochondrial GSK3beta activity results in NADH: ubiquinone oxidoreductase deficiency.

Authors:  Taj D King; Buffie Clodfelder-Miller; Keri A Barksdale; Gautam N Bijur
Journal:  Neurotox Res       Date:  2008-12       Impact factor: 3.911

10.  Wild-type and mutant p53 mediate cisplatin resistance through interaction and inhibition of active caspase-9.

Authors:  Jacqueline L Y Chee; Suzan Saidin; David P Lane; Sai Mun Leong; Jacqueline E Noll; Paul M Neilsen; Yi Ting Phua; Hani Gabra; Tit Meng Lim
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.